ÂÜÀòÂÒÂ×

Hans Hubregtse is an accomplished finance professional with extensive experience in corporate finance leadership across various companies in the healthcare and technology sectors. Currently, Hans serves as Vice President of Corporate Finance at Novocure, a position held since July 2021. Prior to this, Hans held the role of Vice President of Finance at Arvelle Therapeutics International from June 2019 to June 2021. Hans's career also includes significant positions such as Chief Financial Officer Europe at Hitachi Medical Systems, Head of Finance EMEA at ConvaTec, and Director of Finance at Medtronic. Early career roles included managerial positions at NCR, and leadership as Chairman of NCR Stichting Pensioenfonds. Academically, Hans holds a Bachelor's Degree in Business Administration from Windesheim, along with a post-Bachelor Controller qualification from HOFAM in the Netherlands.